Literature DB >> 23616496

Editorial commentary: rifampicin plus colistin in the era of extensively drug-resistant Acinetobacter baumannii infections.

Timothy P Gauthier.   

Abstract

Entities:  

Keywords:  Acinetobacter baumannii; antimicrobial resistance; colistin; rifampicin

Mesh：

Substances：

Year:  2013        PMID： 23616496     DOI： 10.1093/cid/cit262

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

1.  Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections.

Authors:  A Batirel; I I Balkan; O Karabay; C Agalar; S Akalin; O Alici; E Alp; F A Altay; N Altin; F Arslan; T Aslan; N Bekiroglu; S Cesur; A D Celik; M Dogan; B Durdu; F Duygu; A Engin; D O Engin; I Gonen; E Guclu; T Guven; C A Hatipoglu; S Hosoglu; M K Karahocagil; A U Kilic; B Ormen; D Ozdemir; S Ozer; N Oztoprak; N Sezak; V Turhan; N Turker; H Yilmaz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-15       Impact factor: 3.267

2.  Combined Rifampin and Sulbactam Therapy for Multidrug-Resistant Acinetobacter Baumannii Ventilator-Associated Pneumonia in Pediatric Patients.

Authors:  Jinlan Chen; Yifeng Yang; Kun Xiang; David Li; Hong Liu
Journal:  J Anesth Perioper Med       Date:  2018-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.